Lakewood Amedex Biotherapeutics Inc (LABT)

09:30 AM

Lakewood-Amedex backs reintroduced PASTEUR Act legislation - Investing.com

09:30 AM

08:02 AM

Lakewood-Amedex supports PASTEUR Act as Nu-3 heads toward Phase 2 - Stock Titan

08:02 AM

Jul 04, 2026

Price to book forward of Lakewood-Amedex Biotherapeutics Inc. – NASDAQ:LABT - TradingView

Jul 04, 2026

Jul 04, 2026

Lakewood-Amedex Biotherapeutics Company Profile & Introduction - Moomoo

Jul 04, 2026

Jun 27, 2026

Price to sales forward of Lakewood-Amedex Biotherapeutics Inc. – NASDAQ:LABT - TradingView

Jun 27, 2026

Jun 26, 2026

Lakewood-Amedex Biotherapeutics Inc. Actuals & Estimates (NASDAQ:LABT) - TradingView

Jun 26, 2026

Jun 26, 2026

Lakewood-Amedex Biotherapeutics (LABT) Stock Trends and Sentiment 2026 $LABT - MarketBeat

Jun 26, 2026

Jun 26, 2026

Price to earnings forward of Lakewood-Amedex Biotherapeutics Inc. – NASDAQ:LABT - TradingView

Jun 26, 2026

Jun 25, 2026

Lakewood-Amedex Biotherapeutics (LABT) Q1 2026 earnings summary - Quartr

Jun 25, 2026

Jun 25, 2026

Lakewood-Amedex Biotherapeutics (LABT) Life Sciences Virtual Investor Forum Summary - Quartr

Jun 25, 2026

Jun 25, 2026

Lakewood-Amedex names Armstrong as study chair for Phase 2a trial - Investing.com South Africa

Jun 25, 2026

Jun 25, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jun 25, 2026

Jun 25, 2026

Lakewood-Amedex Biotherapeutics Announces World-Renowned Expert David G. Armstrong, M.D., Ph.D., as Study Chair for Phase 2a Trial of Nu-3 in Infected Diabetic Foot Ulcers - PR Newswire

Jun 25, 2026

Jun 25, 2026

Enterprise value to revenue forward of Lakewood-Amedex Biotherapeutics Inc. – NASDAQ:LABT - TradingView

Jun 25, 2026

Jun 24, 2026

Price to earnings forward of Lakewood-Amedex Biotherapeutics Inc. – BOATS:LABT - TradingView

Jun 24, 2026

Jun 23, 2026

Form 13G LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC. For: 23 June By Investing.com - Investing.com South Africa

Jun 23, 2026

Jun 23, 2026

[SCHEDULE 13G] Lakewood-Amedex Biotherapeutics Inc. Passive Investment Disclosure (>5%) - Stock Titan

Jun 23, 2026

Jun 23, 2026

Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin(R) Compounds Being Developed for High-Need Antimicrobial Infections - marketscreener.com

Jun 23, 2026

Jun 22, 2026

1-for-10 Reverse Split Shrinks Share Count (LABT) Ahead of Nasdaq Re‑listing - Stock Titan

Jun 22, 2026

Jun 22, 2026

Lakewood-Amedex (LABT) 1-for-10 reverse split takes effect; new CUSIP 51255A201 - Stock Titan

Jun 22, 2026

Jun 22, 2026

Lakewood-Amedex Biotherapeutics announces new patent in Australia - TipRanks

Jun 22, 2026

Jun 22, 2026

Lakewood-Amedex receives Australian patent for antimicrobials By Investing.com - Investing.com Nigeria

Jun 22, 2026

Jun 22, 2026

Lakewood-Amedex receives Australian patent for antimicrobials - Investing.com

Jun 22, 2026

Jun 22, 2026

Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin® Compounds Being Developed for High-Need Antimicrobial Infections - Morningstar

Jun 22, 2026

Jun 21, 2026

Lakewood-Amedex Biotherapeutics, Inc.(NasdaqCM: LABT) added to S&P TMI Index - marketscreener.com

Jun 21, 2026

Jun 19, 2026

Lakewood-Amedex Biotherapeutics Earnings Date, Reports & Earnings Call - Moomoo

Jun 19, 2026

Jun 17, 2026

Lakewood-Amedex Biotherapeutics plans 1-for-10 reverse stock split - Investing.com

Jun 17, 2026

Jun 17, 2026

Lakewood-Amedex Biotherapeutics plans 1-for-10 reverse stock split By Investing.com - Investing.com Nigeria

Jun 17, 2026

Jun 17, 2026

Lakewood-Amedex (NASDAQ: LABT) plans 1-for-10 reverse stock split - Stock Titan

Jun 17, 2026

Jun 16, 2026

LABT Stock Soars 50% After Nasdaq Debut – Retail Says $14 Is The Line In The Sand - Stocktwits

Jun 16, 2026

Jun 16, 2026

Lakewood-Amedex Biotherapeutics to Present at Life Sciences Virtual Investor Forum - Yahoo Finance

Jun 16, 2026

Jun 16, 2026

Lakewood-Amedex highlights Nu-3 gel for infected diabetic foot ulcers - Stock Titan

Jun 16, 2026

Jun 12, 2026

LABT Price Today: Lakewood-Amedex Biotherapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC

Jun 12, 2026

Jun 12, 2026

Lakewood-Amedex Biotherapeutics (LABT) Stock Price, News & Analysis $LABT - MarketBeat

Jun 12, 2026

Jun 02, 2026

Lakewood-Amedex stock falls despite positive Nu-3 manufacturing update - MSN

Jun 02, 2026

May 29, 2026

Meet Lakewood-Amedex Biotherapeutics: Fly exclusive with CEO Kelvin Cooper - TipRanks

May 29, 2026

May 29, 2026

Lakewood-Amedex Biotherapeutics(LABT) Stock Options Chain | Quotes & News - Moomoo

May 29, 2026

May 28, 2026

Lakewood-Amedex selects PERI as CRO for Nu-3 phase 2 trial - Investing.com Nigeria

May 28, 2026

May 27, 2026

Lakewood-Amedex Expands Global IP Portfolio for Lead Candidate, Nu-3, Targeting Infected Diabetic Foot Ulcers - GuruFocus

May 27, 2026

May 27, 2026

Lakewood-Amedex Biotherapeutics issued two new patents - TipRanks

May 27, 2026

May 27, 2026

Lakewood-Amedex receives patents in Australia, New Zealand By Investing.com - Investing.com South Africa

May 27, 2026

May 27, 2026

Lakewood-Amedex receives patents in Australia, New Zealand - Investing.com Australia

May 27, 2026